Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Revenue | ||||
| Total Revenue | $ 657,458 | $ 1,422,235 | $ 3,355,808 | $ 7,029,538 |
| Cost of goods sold | 73,359 | 402,209 | 974,471 | 2,061,519 |
| Gross profit | 584,099 | 1,020,026 | 2,381,337 | 4,968,019 |
| Operating expenses: | ||||
| Research and development expenses | 1,532,362 | 829,815 | 3,400,149 | 2,610,038 |
| General and administrative expenses | 626,139 | 1,165,187 | 2,449,194 | 2,947,847 |
| Sales and marketing expenses | 273,605 | 483,138 | 901,640 | 1,606,236 |
| Amortization of acquisition intangible assets | 100,537 | 60,717 | 326,614 | |
| Goodwill impairment | 10,857,600 | 10,857,600 | ||
| Change in fair value of acquisition contingent consideration | 26,012 | 16,417 | 87,492 | |
| Total operating expenses | 13,289,706 | 2,604,689 | 17,685,717 | 7,578,227 |
| Loss from operations before other income | (12,705,607) | (1,584,663) | (15,304,380) | (2,610,208) |
| Other income: | ||||
| Gain on sale of business | 240,000 | |||
| Interest income | 22,376 | 82,461 | 122,251 | 119,686 |
| Net loss | $ (12,683,231) | $ (1,502,202) | $ (14,942,129) | $ (2,490,522) |
| Basic net loss per share | $ (0.60) | $ (0.07) | $ (0.71) | $ (0.13) |
| Diluted net loss per share | $ (0.60) | $ (0.07) | $ (0.71) | $ (0.13) |
| Weighted-average common shares used to compute basic net loss per share | 21,076,506 | 20,999,445 | 21,072,444 | 19,161,661 |
| Weighted-average common shares used to compute diluted net loss per share | 21,076,506 | 20,999,445 | 21,072,444 | 19,161,661 |
| Software Services [Member] | ||||
| Revenue | ||||
| Total Revenue | $ 443,189 | $ 1,283,287 | $ 2,866,391 | $ 6,641,652 |
| Software License [Member] | ||||
| Revenue | ||||
| Total Revenue | 209,428 | 138,948 | 461,159 | 387,886 |
| Royalty Income [Member] | ||||
| Revenue | ||||
| Total Revenue | $ 4,841 | $ 28,258 | ||
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of asset in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|